Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 317

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 317
---
 |
| *                 |     | Director                                     |     | October 24, 2025 |
| Jeff Dykan        |     |                                              |     |                  |
| *                 |     | Director                                     |     | October 24, 2025 |
| Keith Valentine   |     |                                              |     |                  |

| * /s/ Dr. Eli Hazum |
| Dr. Eli Hazum       |
| Attorney-in-fact    |

<div align='center'>II-9

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, the undersigned, Puglisi & Associates, the duly authorized representative in the United
States of Regentis Biomaterials Ltd., has signed this Registration Statement on this 24 day of October, 2025.

| Puglisi & Associates           |                   |
| Authorized U.S. Representative |                   |
| /s/                            
 Donald J. Puglisi              |                   |
| Name:                          | Donald J. Puglisi |
| Title:                         | Managing Director |

<div align='center'>II-10</div>